APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meropenem Powder Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Meropenem Powder Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchMeropenem Powder Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Meropenem Powder Injection Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Meropenem Powder Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meropenem Powder Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Meropenem Powder Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Meropenem Powder Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meropenem Powder Injection include Chongqing Shenghuaxi Pharma, Haikou Pharmaceutical Factory, Luoxin Pharna, Hisun, Shanghai Pharma, United Laboratories, Sumitomo Pharma, PKU HealthCare and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Meropenem Powder Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Meropenem Powder Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Meropenem Powder Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meropenem Powder Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Meropenem Powder Injection Segment by Company

Chongqing Shenghuaxi Pharma

Haikou Pharmaceutical Factory

Luoxin Pharna

Hisun

Shanghai Pharma

United Laboratories

Sumitomo Pharma

PKU HealthCare

Pfizer

Joincare

Intelicure Lifesciences

CSPC Pharmaceutical Group

Meropenem Powder Injection Segment by Type

1.0g per Vial

0.50g per Vial

0.25g per Vial

Meropenem Powder Injection Segment by Application

Skin and Soft Tissue Infections（SSTI）

Meningitis

Urinary Tract Infection

Gynecological Infections

Septicemia

Other

Meropenem Powder Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Powder Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meropenem Powder Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Powder Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Meropenem Powder Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meropenem Powder Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Meropenem Powder Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Meropenem Powder Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Meropenem Powder Injection Industry Trends Table 2. Meropenem Powder Injection Industry Drivers Table 3. Meropenem Powder Injection Industry Opportunities and Challenges Table 4. Meropenem Powder Injection Industry Restraints Table 5. Global Meropenem Powder Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Meropenem Powder Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Meropenem Powder Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Meropenem Powder Injection Sales Market Share by Manufacturers Table 9. Global Meropenem Powder Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Meropenem Powder Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Meropenem Powder Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Meropenem Powder Injection Manufacturers, Product Type & Application Table 13. Global Meropenem Powder Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Meropenem Powder Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1.0g per Vial Table 17. Major Manufacturers of 0.50g per Vial Table 18. Major Manufacturers of 0.25g per Vial Table 19. Global Meropenem Powder Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Meropenem Powder Injection Sales by Type (2021-2026) & (K Units) Table 21. Global Meropenem Powder Injection Sales by Type (2027-2032) & (K Units) Table 22. Global Meropenem Powder Injection Sales Market Share by Type (2021-2026) Table 23. Global Meropenem Powder Injection Sales Market Share by Type (2027-2032) Table 24. Global Meropenem Powder Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Meropenem Powder Injection Revenue by Type (2021-2026) & (K Units) Table 26. Global Meropenem Powder Injection Revenue by Type (2027-2032) & (K Units) Table 27. Global Meropenem Powder Injection Revenue Market Share by Type (2021-2026) Table 28. Global Meropenem Powder Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Skin and Soft Tissue Infections（SSTI） Table 30. Major Manufacturers of Meningitis Table 31. Major Manufacturers of Urinary Tract Infection Table 32. Major Manufacturers of Gynecological Infections Table 33. Major Manufacturers of Septicemia Table 34. Major Manufacturers of Other Table 35. Global Meropenem Powder Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Meropenem Powder Injection Sales by Application (2021-2026) & (K Units) Table 37. Global Meropenem Powder Injection Sales by Application (2027-2032) & (K Units) Table 38. Global Meropenem Powder Injection Sales Market Share by Application (2021-2026) Table 39. Global Meropenem Powder Injection Sales Market Share by Application (2027-2032) Table 40. Global Meropenem Powder Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Meropenem Powder Injection Revenue by Application (2021-2026) & (K Units) Table 42. Global Meropenem Powder Injection Revenue by Application (2027-2032) & (K Units) Table 43. Global Meropenem Powder Injection Revenue Market Share by Application (2021-2026) Table 44. Global Meropenem Powder Injection Revenue Market Share by Application (2027-2032) Table 45. Global Meropenem Powder Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Meropenem Powder Injection Sales by Region (2021-2026) & (K Units) Table 47. Global Meropenem Powder Injection Sales Market Share by Region (2021-2026) Table 48. Global Meropenem Powder Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Meropenem Powder Injection Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Meropenem Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 52. North America Meropenem Powder Injection Sales by Country (2027-2032) & (K Units) Table 53. Europe Meropenem Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 55. Europe Meropenem Powder Injection Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Meropenem Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Meropenem Powder Injection Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Meropenem Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Meropenem Powder Injection Sales by Country (2027-2032) & (K Units) Table 62. Global Meropenem Powder Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Meropenem Powder Injection Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Meropenem Powder Injection Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Meropenem Powder Injection Revenue Market Share by Region (2021-2026) Table 66. Global Meropenem Powder Injection Revenue Market Share by Region (2027-2032) Table 67. Chongqing Shenghuaxi Pharma Company Information Table 68. Chongqing Shenghuaxi Pharma Business Overview Table 69. Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio Table 71. Chongqing Shenghuaxi Pharma Recent Development Table 72. Haikou Pharmaceutical Factory Company Information Table 73. Haikou Pharmaceutical Factory Business Overview Table 74. Haikou Pharmaceutical Factory Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio Table 76. Haikou Pharmaceutical Factory Recent Development Table 77. Luoxin Pharna Company Information Table 78. Luoxin Pharna Business Overview Table 79. Luoxin Pharna Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Luoxin Pharna Meropenem Powder Injection Product Portfolio Table 81. Luoxin Pharna Recent Development Table 82. Hisun Company Information Table 83. Hisun Business Overview Table 84. Hisun Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Hisun Meropenem Powder Injection Product Portfolio Table 86. Hisun Recent Development Table 87. Shanghai Pharma Company Information Table 88. Shanghai Pharma Business Overview Table 89. Shanghai Pharma Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Shanghai Pharma Meropenem Powder Injection Product Portfolio Table 91. Shanghai Pharma Recent Development Table 92. United Laboratories Company Information Table 93. United Laboratories Business Overview Table 94. United Laboratories Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. United Laboratories Meropenem Powder Injection Product Portfolio Table 96. United Laboratories Recent Development Table 97. Sumitomo Pharma Company Information Table 98. Sumitomo Pharma Business Overview Table 99. Sumitomo Pharma Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sumitomo Pharma Meropenem Powder Injection Product Portfolio Table 101. Sumitomo Pharma Recent Development Table 102. PKU HealthCare Company Information Table 103. PKU HealthCare Business Overview Table 104. PKU HealthCare Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. PKU HealthCare Meropenem Powder Injection Product Portfolio Table 106. PKU HealthCare Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Pfizer Meropenem Powder Injection Product Portfolio Table 111. Pfizer Recent Development Table 112. Joincare Company Information Table 113. Joincare Business Overview Table 114. Joincare Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Joincare Meropenem Powder Injection Product Portfolio Table 116. Joincare Recent Development Table 117. Intelicure Lifesciences Company Information Table 118. Intelicure Lifesciences Business Overview Table 119. Intelicure Lifesciences Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Intelicure Lifesciences Meropenem Powder Injection Product Portfolio Table 121. Intelicure Lifesciences Recent Development Table 122. CSPC Pharmaceutical Group Company Information Table 123. CSPC Pharmaceutical Group Business Overview Table 124. CSPC Pharmaceutical Group Meropenem Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio Table 126. CSPC Pharmaceutical Group Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Meropenem Powder Injection Distributors List Table 130. Meropenem Powder Injection Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Meropenem Powder Injection Product Image Figure 2. Global Meropenem Powder Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meropenem Powder Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Meropenem Powder Injection Sales (2021-2032) & (K Units) Figure 5. Global Meropenem Powder Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Meropenem Powder Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1.0g per Vial Image Figure 9. 0.50g per Vial Image Figure 10. 0.25g per Vial Image Figure 11. Global Meropenem Powder Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Meropenem Powder Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Meropenem Powder Injection Sales Market Share by Type (2021-2032) Figure 14. Global Meropenem Powder Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Meropenem Powder Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Meropenem Powder Injection Revenue Market Share by Type (2021-2032) Figure 17. Skin and Soft Tissue Infections（SSTI） Image Figure 18. Meningitis Image Figure 19. Urinary Tract Infection Image Figure 20. Gynecological Infections Image Figure 21. Septicemia Image Figure 22. Other Image Figure 23. Global Meropenem Powder Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Meropenem Powder Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Meropenem Powder Injection Sales Market Share by Application (2021-2032) Figure 26. Global Meropenem Powder Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Meropenem Powder Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Meropenem Powder Injection Revenue Market Share by Application (2021-2032) Figure 29. North America Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Meropenem Powder Injection Sales Market Share by Country (2021-2032) Figure 31. U.S. Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Meropenem Powder Injection Sales Market Share by Country (2021-2032) Figure 36. Germany Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Meropenem Powder Injection Sales Market Share by Country (2021-2032) Figure 43. China Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Meropenem Powder Injection Sales Market Share by Country (2021-2032) Figure 51. Brazil Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Meropenem Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Meropenem Powder Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Meropenem Powder Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Meropenem Powder Injection Revenue (2021-2032) & (US$ Million) Figure 62. North America Meropenem Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Meropenem Powder Injection Revenue (2021-2032) & (US$ Million) Figure 64. Europe Meropenem Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Meropenem Powder Injection Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Meropenem Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Meropenem Powder Injection Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Meropenem Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Meropenem Powder Injection Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Meropenem Powder Injection Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 1.0g per Vial
  • 0.50g per Vial
  • 0.25g per Vial
Applications
  • Skin and Soft Tissue Infections（SSTI）
  • Meningitis
  • Urinary Tract Infection
  • Gynecological Infections
  • Septicemia
  • Other
Companies covered
  • Chongqing Shenghuaxi Pharma
  • Haikou Pharmaceutical Factory
  • Luoxin Pharna
  • Hisun
  • Shanghai Pharma
  • United Laboratories
  • Sumitomo Pharma
  • PKU HealthCare
  • Pfizer
  • Joincare
  • Intelicure Lifesciences
  • CSPC Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Meropenem Powder Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Meropenem Powder Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Meropenem Powder Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Meropenem Powder Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Meropenem Powder Injection Market Dynamics
  1. 2.1 Meropenem Powder Injection Industry Trends
  2. 2.2 Meropenem Powder Injection Industry Drivers
  3. 2.3 Meropenem Powder Injection Industry Opportunities and Challenges
  4. 2.4 Meropenem Powder Injection Industry Restraints
3 Meropenem Powder Injection Market by Manufacturers
  1. 3.1 Global Meropenem Powder Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Meropenem Powder Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Meropenem Powder Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Meropenem Powder Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meropenem Powder Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Meropenem Powder Injection Manufacturers, Product Type & Application
  7. 3.7 Global Meropenem Powder Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meropenem Powder Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meropenem Powder Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meropenem Powder Injection Tier 1, Tier 2, and Tier 3
4 Meropenem Powder Injection Market by Type
  1. 4.1 Meropenem Powder Injection Type Introduction
  2. 4.1.1 1.0g per Vial
  3. 4.1.2 0.50g per Vial
  4. 4.1.3 0.25g per Vial
  5. 4.2 Global Meropenem Powder Injection Sales by Type
  6. 4.2.1 Global Meropenem Powder Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Meropenem Powder Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Meropenem Powder Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Meropenem Powder Injection Revenue by Type
  10. 4.3.1 Global Meropenem Powder Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Meropenem Powder Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Meropenem Powder Injection Revenue Market Share by Type (2021-2032)
5 Meropenem Powder Injection Market by Application
  1. 5.1 Meropenem Powder Injection Application Introduction
  2. 5.1.1 Skin and Soft Tissue Infections（SSTI）
  3. 5.1.2 Meningitis
  4. 5.1.3 Urinary Tract Infection
  5. 5.1.4 Gynecological Infections
  6. 5.1.5 Septicemia
  7. 5.1.6 Other
  8. 5.2 Global Meropenem Powder Injection Sales by Application
  9. 5.2.1 Global Meropenem Powder Injection Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Meropenem Powder Injection Sales by Application (2021-2032)
  11. 5.2.3 Global Meropenem Powder Injection Sales Market Share by Application (2021-2032)
  12. 5.3 Global Meropenem Powder Injection Revenue by Application
  13. 5.3.1 Global Meropenem Powder Injection Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Meropenem Powder Injection Revenue by Application (2021-2032)
  15. 5.3.3 Global Meropenem Powder Injection Revenue Market Share by Application (2021-2032)
6 Global Meropenem Powder Injection Sales by Region
  1. 6.1 Global Meropenem Powder Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Meropenem Powder Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Meropenem Powder Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Meropenem Powder Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Meropenem Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Meropenem Powder Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Meropenem Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Meropenem Powder Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Meropenem Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Meropenem Powder Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Meropenem Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Meropenem Powder Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Meropenem Powder Injection Revenue by Region
  1. 7.1 Global Meropenem Powder Injection Revenue by Region
  2. 7.1.1 Global Meropenem Powder Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Meropenem Powder Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Meropenem Powder Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Meropenem Powder Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Meropenem Powder Injection Revenue (2021-2032)
  8. 7.2.2 North America Meropenem Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Meropenem Powder Injection Revenue (2021-2032)
  11. 7.3.2 Europe Meropenem Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Meropenem Powder Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Meropenem Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Meropenem Powder Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Meropenem Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Shenghuaxi Pharma
  2. 8.1.1 Chongqing Shenghuaxi Pharma Company Information
  3. 8.1.2 Chongqing Shenghuaxi Pharma Business Overview
  4. 8.1.3 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio
  6. 8.1.5 Chongqing Shenghuaxi Pharma Recent Developments
  7. 8.2 Haikou Pharmaceutical Factory
  8. 8.2.1 Haikou Pharmaceutical Factory Company Information
  9. 8.2.2 Haikou Pharmaceutical Factory Business Overview
  10. 8.2.3 Haikou Pharmaceutical Factory Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio
  12. 8.2.5 Haikou Pharmaceutical Factory Recent Developments
  13. 8.3 Luoxin Pharna
  14. 8.3.1 Luoxin Pharna Company Information
  15. 8.3.2 Luoxin Pharna Business Overview
  16. 8.3.3 Luoxin Pharna Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Luoxin Pharna Meropenem Powder Injection Product Portfolio
  18. 8.3.5 Luoxin Pharna Recent Developments
  19. 8.4 Hisun
  20. 8.4.1 Hisun Company Information
  21. 8.4.2 Hisun Business Overview
  22. 8.4.3 Hisun Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hisun Meropenem Powder Injection Product Portfolio
  24. 8.4.5 Hisun Recent Developments
  25. 8.5 Shanghai Pharma
  26. 8.5.1 Shanghai Pharma Company Information
  27. 8.5.2 Shanghai Pharma Business Overview
  28. 8.5.3 Shanghai Pharma Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Pharma Meropenem Powder Injection Product Portfolio
  30. 8.5.5 Shanghai Pharma Recent Developments
  31. 8.6 United Laboratories
  32. 8.6.1 United Laboratories Company Information
  33. 8.6.2 United Laboratories Business Overview
  34. 8.6.3 United Laboratories Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 United Laboratories Meropenem Powder Injection Product Portfolio
  36. 8.6.5 United Laboratories Recent Developments
  37. 8.7 Sumitomo Pharma
  38. 8.7.1 Sumitomo Pharma Company Information
  39. 8.7.2 Sumitomo Pharma Business Overview
  40. 8.7.3 Sumitomo Pharma Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sumitomo Pharma Meropenem Powder Injection Product Portfolio
  42. 8.7.5 Sumitomo Pharma Recent Developments
  43. 8.8 PKU HealthCare
  44. 8.8.1 PKU HealthCare Company Information
  45. 8.8.2 PKU HealthCare Business Overview
  46. 8.8.3 PKU HealthCare Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PKU HealthCare Meropenem Powder Injection Product Portfolio
  48. 8.8.5 PKU HealthCare Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Meropenem Powder Injection Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Joincare
  56. 8.10.1 Joincare Company Information
  57. 8.10.2 Joincare Business Overview
  58. 8.10.3 Joincare Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Joincare Meropenem Powder Injection Product Portfolio
  60. 8.10.5 Joincare Recent Developments
  61. 8.11 Intelicure Lifesciences
  62. 8.11.1 Intelicure Lifesciences Company Information
  63. 8.11.2 Intelicure Lifesciences Business Overview
  64. 8.11.3 Intelicure Lifesciences Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Intelicure Lifesciences Meropenem Powder Injection Product Portfolio
  66. 8.11.5 Intelicure Lifesciences Recent Developments
  67. 8.12 CSPC Pharmaceutical Group
  68. 8.12.1 CSPC Pharmaceutical Group Company Information
  69. 8.12.2 CSPC Pharmaceutical Group Business Overview
  70. 8.12.3 CSPC Pharmaceutical Group Meropenem Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio
  72. 8.12.5 CSPC Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Meropenem Powder Injection Value Chain Analysis
  2. 9.1.1 Meropenem Powder Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Meropenem Powder Injection Production Mode & Process
  6. 9.2 Meropenem Powder Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Meropenem Powder Injection Distributors
  9. 9.2.3 Meropenem Powder Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst